Last Updated on June 22, 2023

Molecular and Cellular Oncology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Taylor and Francis Ltd.

Abbreviation: Mol. Cell. Oncol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.04

SJR

 0.436

h-Index

 34

Rank

 11686

Important Details

Title Molecular and Cellular Oncology
Standard Abbreviation Mol. Cell. Oncol.
Type of Publication Journal
Discipline Molecular Medicine (Q3); Cancer Research (Q4)
Impact Score 1.04
SCImago Journal Rank (SJR) 0.436
h-index 34
Overall Rank 11686
Publisher Name Taylor and Francis Ltd.
Publication Country United Kingdom
International Standard Serial Number (ISSN) 23723556
Coverage and History 2014-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
340

About Molecular and Cellular Oncology


Molecular and Cellular Oncology is a journal published by Taylor and Francis Ltd.. This journal covers the area[s] related to Molecular Medicine, Cancer Research, etc. The coverage history of this journal is as follows: 2014-2022. The rank of this journal is 11686. This journal's impact score, h-index, and SJR are 1.04, 34, and 0.436, respectively. The ISSN of this journal is/are as follows: 23723556.

The best quartile of Molecular and Cellular Oncology is Q3. This journal has received a total of 340 citations during the last three years (Preceding 2022).


Molecular and Cellular Oncology Impact Score 2022-2023


The latest impact score (IS) of the Molecular and Cellular Oncology is 1.04. It is computed in the year 2023 as per its definition and based on Scopus data. 1.04

It is decreased by a factor of around 0.3, and the percentage change is -22.39% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Molecular and Cellular Oncology Impact Score 2023


Impact Score 2022 of Molecular and Cellular Oncology is 1.04. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Molecular and Cellular Oncology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.04
2021 1.34
2020 1.27
2019 1.01
2018 1.31
2017 1.51
2016 0.55
2015 0.26
2014 0.00

Molecular and Cellular Oncology h-index


  Table Setting

The h-index of Molecular and Cellular Oncology is 34. By definition of the h-index, this journal has at least 34 published articles with more than 34 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Molecular and Cellular Oncology ISSN


The International Standard Serial Number (ISSN) of Molecular and Cellular Oncology is/are as follows: 23723556.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Molecular and Cellular Oncology Ranking and SCImago Journal Rank (SJR)


The Molecular and Cellular Oncology is ranked 11686 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.436.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Molecular and Cellular Oncology Publisher


Table Setting

The publisher of Molecular and Cellular Oncology is Taylor and Francis Ltd.. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2014-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Molecular and Cellular Oncology is Mol. Cell. Oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Mol. Cell. Oncol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Molecular and Cellular Oncology


If your area of research or discipline is related to Molecular Medicine, Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Molecular and Cellular Oncology?

The latest impact score of Molecular and Cellular Oncology is 1.04. It is computed in the year 2023.


What is the h-index of Molecular and Cellular Oncology?

The latest h-index of Molecular and Cellular Oncology is 34. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Molecular and Cellular Oncology?

The latest SCImago Journal Rank (SJR) of Molecular and Cellular Oncology is 0.436. It is calculated in the year 2023.


What is the ranking of Molecular and Cellular Oncology?

The latest ranking of Molecular and Cellular Oncology is 11686. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Molecular and Cellular Oncology?

Molecular and Cellular Oncology is published by Taylor and Francis Ltd.. The publication country of this journal is United Kingdom.


What is the abbreviation of Molecular and Cellular Oncology?

This standard abbreviation of Molecular and Cellular Oncology is Mol. Cell. Oncol..


Is "Molecular and Cellular Oncology" a Journal, Conference or Book Series?

Molecular and Cellular Oncology is a journal published by Taylor and Francis Ltd..


What is the scope of Molecular and Cellular Oncology?

The scope of Molecular and Cellular Oncology is as follows:

  • Molecular Medicine
  • Cancer Research

For detailed scope of Molecular and Cellular Oncology, check the official website of this journal.


What is the ISSN of Molecular and Cellular Oncology?

The International Standard Serial Number (ISSN) of Molecular and Cellular Oncology is/are as follows: 23723556.


What is the best quartile for Molecular and Cellular Oncology?

The best quartile for Molecular and Cellular Oncology is Q3.


What is the coverage history of Molecular and Cellular Oncology?

The coverage history of Molecular and Cellular Oncology is as follows 2014-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Business Economics and Management Journal Vilnius Gediminas Technical University 10343 45 2.81
Dermatologia Kliniczna Journal Cornetis 25442 7 0.00
Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division Conference And Proceedings 17477 16 0.00
Journal of International Financial Management and Accounting Journal Wiley-Blackwell Publishing Ltd 6179 42 6.09
Air and Space Power Journal (discontinued) Journal AU Press 28397 9 0.20
Materials Research Journal Universidade Federal de Sao Carlos 14791 65 1.62
Marine Biology Research Journal Taylor and Francis Ltd. 13573 42 1.06
Abacus Journal Wiley-Blackwell Publishing Ltd 8398 49 2.52
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
Libyan Studies Journal Cambridge University Press 16122 8 0.45

Check complete list




Molecular and Cellular Oncology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.04
2021 1.34
2020 1.27
2019 1.01
2018 1.31
2017 1.51
2016 0.55
2015 0.26
2014 0.00



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All